Guidance
Update information
September 2023: This guideline updates and replaces NICE guideline CG75 (November 2008).
Recommendations on bisphosphonates (labelled [2008]) and denosumab last had an evidence review in 2008. We will review the evidence in a later update to take into account upcoming patent changes. In some cases, minor changes have been made to the wording to bring the language and style up to date, without changing the meaning.